Refine
Year of publication
Document Type
- Article (30)
- Preprint (4)
- Conference Proceeding (1)
- Working Paper (1)
Has Fulltext
- yes (36)
Is part of the Bibliography
- no (36)
Keywords
- functional genetics (2)
- 16p11.2 (1)
- ABC transporters (1)
- AML (1)
- ATPases (1)
- Acquired resistance (1)
- Acute lymphoblastic leukemia (1)
- Acute myeloid leukemia (1)
- Ankylosierende Spondylitis (1)
- Ankylosing spondylitis (1)
- Autism (1)
- Axial spondyloarthritis (1)
- Axiale Spondyloarthritis (1)
- BNC2 (1)
- Biomarker (1)
- Biomarkers (1)
- Bipolar disorder (1)
- Brain development (1)
- Brain repair (1)
- CAKUT (1)
- CNDAC (1)
- COVID-19 (1)
- CRISPR/Cas9 (1)
- CVID (1)
- Cancer (1)
- Care gaps (1)
- DCK (1)
- Dasya (1)
- Diagnostic test (1)
- Differential diagnosis (1)
- Electron-pion identification (1)
- European Society for Immunodeficiencies (ESID) (1)
- Fibre/foam sandwich radiator (1)
- Genetics (1)
- German PID-NET registry (1)
- HDAC (1)
- HDACi (1)
- HMGB1 (1)
- IgG substitution therapy (1)
- Immunogenetics (1)
- Immunology (1)
- Inherited arrhythmic syndrome (1)
- Intrinsic resistance (1)
- Ionisation energy loss (1)
- Kynurenine (1)
- LUT (1)
- Leukemia (1)
- MYC (1)
- Migration (1)
- Molecular autopsy (1)
- Monitoring (1)
- Multi-wire proportional drift chamber (1)
- Multiplex immunoassay (1)
- Neural network (1)
- Neural stem cells (1)
- Neurogenesis (1)
- Oncology (1)
- Oposterior urethral valve (1)
- PID prevalence (1)
- Pandemic (1)
- Post-mortem genetic screening (1)
- Preclinical research (1)
- Psychiatric disorders (1)
- Quality of care (1)
- Quality standards (1)
- Qualitätsstandards (1)
- Quinolinate phosphoribosyltransferase (1)
- Quinolinic acid (1)
- Rhodophyta (1)
- SAMHD1 (1)
- SLC20A1 (1)
- Sapacitabine (1)
- Sholl analysis (1)
- Sudden cardiac death (1)
- Sudden death (1)
- Suicide (1)
- TR (1)
- Tracking (1)
- Transition radiation detector (1)
- Translational research (1)
- Trigger (1)
- VEGF (1)
- VEGF receptors (1)
- VUS (1)
- Versorgungslücken (1)
- Versorgungsqualität (1)
- WT1 (1)
- Western Atlantic (1)
- X-ray crystallography (1)
- Xenon-based gas mixture (1)
- adaptation (1)
- basonuclin 2 (1)
- bevacizumab (1)
- bladder exstrophy-epispadias complex (1)
- cloacae (1)
- cloacal malformation (1)
- cryo-EM (1)
- dE/dx (1)
- damage associated molecular pattern (1)
- distal pronephric outlet obstruction (1)
- drug resistance (1)
- ectosomes (1)
- evolution (1)
- exosomes (1)
- extracellular vesicles (1)
- guidelines (1)
- hepatitis C virus (HCV) (1)
- indomethacin (1)
- kidney formation (1)
- lower urinary tract obstruction (1)
- membrane proteins (1)
- mesophotic zone (1)
- microparticles (1)
- microvesicles (1)
- minimal information requirements (1)
- mitochondrial antiviral signaling protein (MAVS) (1)
- molecular adaptation (1)
- molecular biology (1)
- molecular dynamics (1)
- molecular machines (1)
- molecular marker (1)
- phylogeny (1)
- primary active transporters (1)
- primary immunodeficiency (PID) (1)
- pronephric development (1)
- protease inhibitor (1)
- registry for primary immunodeficiency (1)
- renal cell carcinoma (1)
- replicative fitness (1)
- reproducibility (1)
- resistance mutation (1)
- rigor (1)
- sequence alignment (1)
- serine protease (NS3-4A) (1)
- standardization (1)
- structural biology (1)
- structure constraints (1)
- urinary tract development (1)
- zebrafish (1)
- zebrafish development (1)
- β-catenin (1)
Institute
- Medizin (18)
- Physik (8)
- Biochemie und Chemie (3)
- Frankfurt Institute for Advanced Studies (FIAS) (3)
- Informatik (3)
- Biodiversität und Klima Forschungszentrum (BiK-F) (1)
- Biowissenschaften (1)
- Center for Financial Studies (CFS) (1)
- Center for Scientific Computing (CSC) (1)
- Exzellenzcluster Makromolekulare Komplexe (1)
Highlights
• A panel of 20 biomarkers was identified capable of differentiating BD patients from controls.
• Excellent discrimination between established BD patients and controls.
• Good to excellent discrimination between misdiagnosed BD patients and first onset MDD patients.
• Fair to good discrimination between pre-diagnostic BD patients and controls.
• Study demonstrates the potential utility of a protein biomarker panel as a diagnostic test for BD.
Abstract
Background: Bipolar disorder (BD) is a costly, devastating and life shortening mental disorder that is often misdiagnosed, especially on initial presentation. Misdiagnosis frequently results in ineffective treatment. We investigated the utility of a biomarker panel as a diagnostic test for BD.
Methods and findings: We performed a meta-analysis of eight case-control studies to define a diagnostic biomarker panel for BD. After validating the panel on established BD patients, we applied it to undiagnosed BD patients. We analysed 249 BD, 122 pre-diagnostic BD, 75 pre-diagnostic schizophrenia and 90 first onset major depression disorder (MDD) patients and 371 controls. The biomarker panel was identified using ten-fold cross-validation with lasso regression applied to the 87 analytes available across the meta-analysis studies.
We identified 20 protein analytes with excellent predictive performance [area under the curve (AUC) ⩾ 0.90]. Importantly, the panel had a good predictive performance (AUC 0.84) to differentiate 12 misdiagnosed BD patients from 90 first onset MDD patients, and a fair to good predictive performance (AUC 0.79) to differentiate between 110 pre-diagnostic BD patients and 184 controls. We also demonstrated the disease specificity of the panel.
Conclusions: An early and accurate diagnosis has the potential to delay or even prevent the onset of BD. This study demonstrates the potential utility of a biomarker panel as a diagnostic test for BD.